Overall, there was an increase in CD13 expression in the BTB and BAT in NSCLC brain metastases; this trend was most prominent at week 4 (BTB 2.42-fold (p = 0.001); BAT 1.78-fold (p < 0.001)). Here, ANPEP is linked to non-small cell lung carcinoma.